Herpes Zoster Therapeutics – Pipeline Assessment And Market Forecasts To 2017

The herpes zoster market is predicted to witness a significant rise over the next few years following the launch of two vaccines in major markets. In 2006 Merck launched zostavax, which is the only vaccine approved in the US for the prevention of herpes zoster. It is awaiting its launch in other major markets, expected in 2011. GlaxoSmithKline Biologicals GSK1437173A vaccine is under Phase III trial and is expected to launch in the coming years. GlobalDatas analysis suggests that the global herpes zoster market was worth $651m in 2010. The market is forecast to show a rise in compound annual growth rate (CAGR) of 11%, following the patent launch of vaccines GSK1437173A and V212 (Zostavax) in major markets.

GlobalDatas pipeline analysis revealed that there are nine candidates in the various stages of clinical development. Phase II has five pipeline molecules. There is only one molecule in Phase I. However the molecules ARYS-01 by aRigen Pharmaceuticals, EPB-348 by Epiphany Biosciences, and ASP2151 by Astellas Pharma Inc. are expected to be promising candidates for the herpes zoster market. The pipeline molecules differ from each other in terms of mechanism of action, and can further capture the current market on approval.

For Sample Pages, please click or add the below link to your browser:

prescribed by medical practitioners to treat the symptoms of the disease. To reduce the risk factor and prevent the disease, adults above 60 years of age are vaccinated with zostavax, which is a live attenuated vaccine developed by Merck & Co.
The unmet need for the herpes zoster therapeutics market was estimated to be approximately $87m, and for the prophylactic market it is estimated to be $79m. Currently there are significant patient populations that are likely to switch over to new products with better efficacy and safety.

GlobalData, the industry analysis specialist, has released its new report, Herpes Zoster Therapeutics – Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global herpes zoster market. The report identifies the key trends shaping and driving the global herpes zoster market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global herpes zoster sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
For further details, please click or add the below link to your browser:

Visit our report store:

For more details contact:

North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

Germany Dental Devices Market Analysis And Forecasts To 2015

Browse Complete Report: Germany Dental Devices Market

This report is an essential source for in-depth information and data relating to the Germany dental devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the dental devices market in Germany.

Scope
The report provides dental devices market information broken down into detailed categories and segments in Germany.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors. Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy
Gain a strong understanding of the dental devices market in Germany.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Buy Now: Market Research
Browse All: Dental Devices Market
Browse: Germany Market

Related Reports:
Global Dental Devices Market Analysis and Forecasts to 2015
Japan Dental Devices Market Analysis and Forecasts to 2015
Canada Dental Devices Market Analysis and Forecasts to 2015

Japan Dental Devices Market Analysis And Forecasts To 2015

Browse Complete Report: Japan Dental Devices Market

GlobalDatas Japan Dental Devices Market Analysis and Forecasts to 2015 report provides key data, information and analysis on the Japan dental devices market. The report provides market landscape, competitive landscape and market trends information on seven market categories including crowns and bridges, dental chairs and equipment, dental implants, dental lasers, dental biomaterials and dental radiology equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope
Forecasts & Analysis of the Japan dental devices market to 2015.
Market segmentation by crowns and bridges, dental chairs and equipment, dental implants, dental lasers, dental biomaterials and dental radiology equipment.
Market Analysis from 2001 to 2008, including new updated 2008 data.
Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
Analysis of key dental devices pipeline products, new technologies and clinical trials.
Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy
Understand what the new growth opportunities are within the Japan dental devices market.
Develop a clear knowledge & understanding of the Japan dental devices competitor landscape and how this will change to 2015.
Identify acquisition opportunities across the Japan dental devices market.
Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.

Buy Now: Market Research
Browse All: Dental Devices Market
Browse: Japan Market

Related Reports:
Global Dental Devices Market Analysis and Forecasts to 2015
Canada Dental Devices Market Analysis and Forecasts to 2015
UK Dental Devices Market Analysis and Forecasts to 2015

Synthetic Biology Market – Global Industry Analysis, Size, Share And Forecasts, 2012 – 2018

The global market for synthetic biology is estimated to grow to $4.5 billion over the year 2015 owing to the developments in fields like biomedicine, biopharmaceutical synthesis, energy and environment, biosecurity, sustainable chemical segment, and biomaterials. Significant investments by major companies and emergence of new players in the market are also expected to boost the growth of this industry.

Browse : Synthetic Biology Market

.
Synthetic biology is the fastest growing segment of the biotechnology field having number of applications. Synthetic biology provides significant number of near future commercial opportunities. Despite its emerging status, the list of applications is continuously growing. Some of these major applications include chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms among others.

Current developments in technologies like DNA synthesis and sequencing, specialty media, and bioinformatics, and the need for renewable feedstock are driving the market for synthetic biology. Rapid developments in this field are creating unique market opportunities and contributing to the growth of this field.

Synthetic biology is gaining tremendous recognition as a transformative technology as it has the ability to address food storage and security issues as well as handle other threats like climate change, energy shortage, and water deficits.

This research report is a comprehensive analysis of current industry trends, industry growth drivers, restraints, industry capacity, market structure, and market projections for upcoming years. The report also includes analysis of technological developments in the market, Porters five force model analysis, and complete company profiles of top industry players.
It provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis.
.
Browse : Synthetic Biology Industry

.
Major Players

Major players dominating this market are Amyris Biotechnologies Inc., ATG Biosynthetics GmbH, Blue Heron Biotechnology Inc., Chromatin Inc., Draths Corp., febit Synbio GmbH, GENEART AG, GenScript USA Inc., Joule Biotechnologies Inc., LC Sciences, LS9 Inc., OPXBIO Inc., Solazyme Inc., Sloning BioTechnology GmbH, Synthetic Genomics Inc., Verdezyne Inc, and others.

Read More :